Thymidine phosphorylase (TP) catalyzes the cleavage of thymidine into thymine and 2-deoxy-á-d-ribose-1-phosphate. Elevated activity of TP prevents apoptosis, and induces angiogenesis which ultimately leads to tumor growth and metastasis. Critical role of TP in cancer progression makes it a valid target in anti-cancer research. Discovery of small molecules as TP inhibitors is vigorously pursued in cancer therapy. In the present study, we functionalized thymidine as benzoyl ester to synthesize compounds 3-16. In vitro evaluation of thymidine esters for their thymidine phosphorylase inhibition activity was subsequently carried out. Compounds 4, 10, 14, and 15 showed good activities with lower IC50 values than the standard, 7-deazaxanthine (IC50=41.0±1.63ìM). Among them, compound 14 showed five folds higher activity (IC50=7.5±0.8ìM), while 4 (IC50=18.5±1.0ìM) and 10 (IC50=18.8±1.2ìM) showed two folds higher activity than the standard. Compound 15 showed slightly better activity (IC50=33.3±1.5ìM) to the standard. Potent compounds were further subjected to kinetic and molecular docking studies to identify their mode of inhibition, and to study their interactions with the protein at atomic level, respectively. All active compounds were non-cytotoxic to mouse fibroblast 3T3 cell line. These results identify thymidine esters as substrate analogue (substrate-like) inhibitors of angiogenic enzyme thymidine phosphorylase for further studies.
3T3 Cells Animals